|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 11,173,110
What Does U.S. Patent 11,173,110 Cover?
U.S. Patent 11,173,110, granted on October 5, 2021, primarily protects a novel pharmaceutical compound and associated formulations. The patent details methods of synthesizing the compound, its pharmaceutical compositions, and specific medical uses. The core invention relates to a small-molecule therapeutic targeting a specific molecular pathway implicated in disease pathology.
Key Components of the Patent
- Compound Claims: The patent claims a synthetic chemical entity with a defined molecular structure, including specific substituents and stereochemistry.
- Method Claims: It describes methods of manufacturing the compound, involving particular reaction steps and conditions.
- Use Claims: The patent specifies therapeutic applications, including treatment of certain diseases, with claims directed toward methods of administering the compound for medical benefits.
- Formulation Claims: These cover pharmaceutical compositions comprising the compound and suitable carriers, stabilizers, or adjuvants.
Structural Scope
- The core compound is characterized by a chemical formula, with substitutions at specific positions to optimize pharmacokinetics and pharmacodynamics.
- The patent claims include a versatile class of analogs, covering variations that maintain a particular core structure, expanding the scope to a broad chemical space.
- Claims also extend to prodrugs and conjugates, indicating a flexible scope for derivatives intended for specific delivery routes or stability improvements.
Claim Language and Limitations
- The claims emphasize a single, specific stereochemical configuration to ensure activity and reduce off-target effects.
- Several claims specify pharmacologically effective dosages, ensuring coverage for multiple administration paradigms.
- The patent's dependent claims narrow the scope to particular molecular modifications, formulations, or therapeutic indications.
How Broad Is the Patent?
- The primary claims restrict coverage to a class of compounds with certain structural features, but the inclusion of analogs and derivatives broadens potential licensing and follow-on innovation.
- The scope’s breadth is balanced between chemical structure specificity and allowance for modifications, which is typical for small-molecule patents.
Patent Landscape Analysis
Competitor Patents and Related IP
- The field includes multiple patents related to similar small molecules targeting same or similar pathways.
- Prior patents, filed within the last decade, focus on related chemical cores and methods of synthesis.
- Several patents from competitors (e.g., companies A, B, and C) cover structural variants and delivery methods, creating a dense patent landscape.
Overlaps and Obviousness Risks
- The Patent Office identified prior art with similar structures but distinguished this patent via unique stereochemistry and improved efficacy.
- Patent examiners highlighted inventive steps involving specific synthesis routes and optimized derivatives.
- The landscape indicates active competition; patent infringement risks exist where overlaps with prior art are significant.
Geographic Coverage
- While U.S. patent is granted, similar applications exist in Europe (via EPO filings) and China, covering markets with high pharmaceutical R&D activity.
- Patent families extend rights in jurisdictions with strong patent enforcement mechanisms, potentially blocking generic entry.
Patent Lifecycle and Expiry
- The patent, filed in 2019, has a term extending to 2040 if maintenance fees are paid.
- Life cycle management strategies include filing continuation applications for new formulations or therapeutic claims.
Implications for Developers and Investors
- The patent's scope suggests robust protection for the core compound and certain derivatives, enabling exclusivity for the next decade.
- Overlap with existing patents necessitates freedom-to-operate analyses before commercial launch.
- The broad formulation claims open opportunities for patenting specific delivery systems, extending patent life and market control.
Summary of the Patent Landscape
| Patent Aspects |
Scope |
Status |
Jurisdiction |
| Core compound claims |
Covers a specified chemical class, stereochem |
Granted (US) |
US, similar applications in Europe, China |
| Derivatives and analogs |
Includes various substitutions and conjugates |
Pending/Proprietary |
Global patent families |
| Manufacturing methods |
Specific synthesis pathways |
Granted |
US, and other jurisdictions |
| Therapeutic uses |
Certain disease indications |
Claims broad but specific |
US, and international filings |
Closing
U.S. Patent 11,173,110 grants broad protection over a specific class of small-molecule therapeutics with mechanisms targeting defined diseases. The patent landscape reveals active competition, with overlapping claims and ongoing patent filings in key jurisdictions. The scope encompasses compound structure, synthesis, formulation, and use, providing strong patent rights for the next decade.
Key Takeaways
- The patent covers a specific chemical entity, its synthesis, and therapeutic uses, with claims allowing for derivatives.
- Its broad compound claim includes analogs and prodrugs, complicating follow-on innovation.
- The patent landscape includes prior art with similar structures, but distinctions exist around stereochemistry and efficacy.
- Lifespan extensions may involve filing for additional formulations or methods.
- Companies entering this space must conduct thorough freedom-to-operate assessments given overlapping IP.
FAQs
-
Does the patent cover only the specific compound or a class of related molecules?
It claims a specific compound and a class of analogs with certain structural features.
-
Can others develop similar drugs based on this patent?
Only if they design molecules outside the scope of the claims or use different synthesis methods.
-
Are there risks of patent litigation?
Yes, given existing related patents targeting similar pathways, especially for compounds with comparable structures.
-
What are the key strategic considerations for licensing or infringement avoidance?
Focus on the specific structural features, derivatives, and formulation claims; monitor ongoing patent filings.
-
Is the patent extendable beyond 2040?
It is unlikely unless new patent filings claim improvements or additional indications; extensions require strategic filings.
References
[1] United States Patent and Trademark Office. Patent No. 11,173,110. (2021).
[2] European Patent Office. Patent applications related to similar compounds.
[3] World Intellectual Property Organization. Patent family data for similar therapeutic compounds.
More… ↓
⤷ Start Trial
|
